Furthermore, in their respective disease mechanisms, pathways such as amyloid precursor protein biosynthesis and positive regulation of neuroinflammatory responses in AD, as well as positive regulation of macrophage-derived foam cell differentiation in AS, showed significant activation in the C2 compared to the C1 subtype. The gene discussed is APP; the disease is Alzheimer disease.